Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The National HealthCare Corporation (NHC) SEC filings page provides access to the company’s regulatory disclosures as a NYSE American issuer. NHC’s common stock, with a par value of $0.01 per share, is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades under the symbol NHC. Through its affiliates, the company operates skilled nursing facilities, assisted living and independent living communities, behavioral health hospitals, homecare agencies, and hospice agencies, along with Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and management and accounting services to third party post-acute operators.
In its Form 8-K current reports, NHC discloses material events such as quarterly and annual earnings releases, dividend declarations, and significant lease and governance matters. For example, the company files 8-Ks to furnish earnings press releases for periods ended March 31, June 30, September 30, and December 31, and to announce quarterly common dividends. These filings often reference non-GAAP financial measures and include or incorporate reconciliations to GAAP results.
NHC’s 8-K filings also describe corporate governance and executive changes, including the appointment of new directors, committee assignments, and planned retirements of senior officers, as well as role changes for executives. Additional 8-Ks address lease arrangements, such as disclosures about a master lease with National Health Investors, Inc., letters alleging non-monetary non-compliance, cure periods, renewal options, and the potential for a material adverse impact on NHC’s financial position and results of operations if certain lease rights were lost.
On this page, users can review NHC’s SEC reports as they are made available through EDGAR and use AI-powered summaries to understand the key points in lengthy filings. These tools can help clarify topics such as segment reporting for inpatient services and home care hospice services, dividend practices, lease terms and disputes, and board and executive leadership changes, without replacing the full text of the official documents.
National Healthcare Corp director James Paul Abernathy exercised stock options and increased his direct shareholdings. He exercised options covering 3,140 shares of common stock at an exercise price of $55.75 per share, receiving 3,140 common shares. Following the transaction, he directly owns 43,302 common shares.
The exercised options were part of a 2023 grant under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d). Abernathy still holds two additional option grants, each linked to 7,500 underlying common shares, with exercise prices of $96.03 and $94.66 per share and expirations in 2029 and 2030.
NATIONAL HEALTHCARE CORP Sr. VP of Patient Services Vicki L. Dodson reported option-related transactions in company stock. On March 4, 2026, she exercised 4,500 stock options granted under the 2020 Omnibus Equity Incentive Plan, receiving 4,500 common shares at an exercise price of $0.00 per share and a corresponding entry at $90.62 per share for the acquired stock.
In a separate transaction coded "F," 3,159 shares of common stock were withheld by the company to cover the exercise price and tax-withholding obligations, rather than sold on the open market. Following these transactions, she beneficially owns 12,712.5455 shares of NATIONAL HEALTHCARE CORP common stock directly, and continues to hold multiple option awards with remaining exercisable balances.
National HealthCare Corp senior VP & CIO Ben Anderson Sr reported option exercises and related share withholdings. On March 4, 2026 he exercised multiple “Option to Purchase Common Stock” grants under the 2020 Omnibus Equity Incentive Plan into common shares. The company then withheld a portion of common stock to cover the exercise price and tax obligations, as noted in the footnotes. Following these transactions, he beneficially owned a total of 19,550.0547 shares of National HealthCare Corp common stock.
NATIONAL HEALTHCARE CORP Senior VP & General Counsel Josh A. McCreary reported option-related transactions in company stock. On March 4, 2026, he exercised options for 4,500 shares of common stock at an exercise price of $90.62 per share.
To cover the exercise price and related tax withholding obligations, 3,202 shares of common stock were withheld by the company, classified as a tax-withholding disposition rather than an open-market sale. Following these transactions, McCreary directly beneficially owned 12,698 shares of NATIONAL HEALTHCARE CORP common stock.
National Healthcare Corp senior executive exercises stock options and settles taxes in shares
Timothy J. Shelly, Sr. VP Operations of National Healthcare Corp, exercised options to purchase 2,667 and 3,667 shares of common stock on March 4, 2026. These options were granted under the 2020 Omnibus Equity Incentive Plan, as noted in the footnotes.
In connection with these exercises, 4,481 shares of common stock were withheld by the company to pay the option exercise price and related tax obligations. After these transactions, Shelly held 3,147 shares of common stock directly, along with 2,400 and 14,000 options to purchase common stock.
National Healthcare Corp (NHC) senior vice president and CFO Brian F. Kidd reported option exercises and related share withholdings in company stock. On March 4, 2026, he exercised options for 2,000 shares of common stock at $53.94 per share and 4,000 shares at $90.62 per share under the 2020 Omnibus Equity Incentive Plan. The filing shows a tax-related disposition of 3,947 shares of common stock at $172.83 per share, with shares withheld by the company to pay the exercise price and withholding taxes. Following these transactions, Kidd beneficially owned 27,277 shares of common stock and held options to purchase 8,000 and 14,000 shares, all as direct ownership.
NATIONAL HEALTHCARE CORP director David R. Gifford filed an initial statement of beneficial ownership on Form 3. The filing identifies him as a director of the company and, based on the structured data, shows no reported insider purchase, sale, acquisition, or disposition transactions at this time.
Dodson Vicki L reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president Vicki L. Dodson received an equity award of 1,082 shares of common stock. The award was granted at no cash cost to her and increased her directly held common stock to 11,371.5455 shares.
The 1,082 shares are restricted stock that vest over three years. One-third is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029, encouraging longer-term alignment with the company.
Shelly Timothy J. reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president of operations Timothy J. Shelly received an equity award of 1,294 shares of common stock on February 27, 2026. The award was granted at $0.00 per share, indicating a stock-based compensation grant rather than an open-market purchase.
The granted shares are restricted and follow a three-year vesting schedule. One-third of the award is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029. The filing also lists existing stock options, showing post-transaction holdings of 2,400, 8,000, 11,000, and 14,000 options under various grants, all held directly.
National Healthcare Corp CEO Stephen Fowler Flatt reported several equity transactions involving company stock. He exercised options to acquire 5,000 shares of common stock on
As part of the same event, 3,585 shares of common stock were withheld by the company at a price of